British scientists are working on a vaccine against Disease X, the hypothetical pathogen that will cause the next pandemic.
A breakthrough in solid-state storage of biological materials has potential applications in healthcare and research.
TAU’s groundbreaking study shows that tension enhances antibody quantity and quality but impairs immunological memory.
If successful, the scheme – known as the global virtual pooled inventory (GVPI) – could be a pilot for other deadly diseases and wider pandemic preparedness.
A new, effective vaccine is available from the four health funds to the elderly and immunocompromised against shingles.
After several months of no cases in Israel, a man in his 50s has been diagnosed with monkeypox.
The next-generation shots should select a single XBB-related target, the FDA's staff reviewers suggested.
"These favorable results provided sufficient guarantees to launch a vaccination campaign as early as autumn 2023," the farm ministry wrote on its website.
For many people, the arbitrary nature of the pandemic, with tough rules one day about things like masks, and then rules discarded the next, has left an imprint.
The researchers decided to work with a novel type of vaccine delivery based on patches about the size of a thumbnail that contain hundreds of microneedles.
JPOST Digital Library
